| Stem definition | Drug id | CAS RN |
|---|---|---|
| corticosteroids, except prednisolone derivatives | 822 | 808-48-0 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA | NOVARTIS |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
| CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
None
| Species | Use | Relation |
|---|---|---|
| Dogs | Mineralocorticoid deficit with primary adrenocortical insufficiency (Addisons disease) | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Percorten-V | Elanco US Inc. | 1 |
| Zycortal Suspension | Dechra, Ltd. | 1 |
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Mineralocorticoid receptor | Nuclear hormone receptor | AGONIST | EC50 | 11 | WOMBAT-PK | CHEMBL |
| ID | Source |
|---|---|
| 4018521 | VUID |
| N0000179098 | NUI |
| D03699 | KEGG_DRUG |
| 22537 | RXNORM |
| 4018521 | VANDF |
| 4019710 | VANDF |
| C0057420 | UMLSCUI |
| CHEBI:50782 | CHEBI |
| CHEBI:16973 | CHEBI |
| CHEMBL1200592 | ChEMBL_ID |
| CHEMBL1401691 | ChEMBL_ID |
| DB01134 | DRUGBANK_ID |
| C019323 | MESH_SUPPLEMENTAL_RECORD_UI |
| 11876263 | PUBCHEM_CID |
| 16665T4A2X | UNII |
| DB15972 | DRUGBANK_ID |
| 002207 | NDDF |
| 002209 | NDDF |
| 116630009 | SNOMEDCT_US |
| 1336006 | SNOMEDCT_US |
| 56156001 | SNOMEDCT_US |
| 75029008 | SNOMEDCT_US |
| C0011710 | UMLSCUI |
| 387 | INN_ID |
| 6166 | PUBCHEM_CID |
None